This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/515925-thailand-domestically-developed-covid-vaccine-human-trials/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| Thailand’s second domestically developed Covid-19 vaccine to start human trials | Thailand’s second domestically developed Covid-19 vaccine to start human trials |
| (7 months later) | |
| Thailand’s Chulalongkorn University has announced that the country’s second domestically developed vaccine is set to start human trials, and researchers hope to produce up to five million doses of the jab by the end of 2021. | Thailand’s Chulalongkorn University has announced that the country’s second domestically developed vaccine is set to start human trials, and researchers hope to produce up to five million doses of the jab by the end of 2021. |
| The ‘ChulaCov19’ vaccine has proved effective in tests that have been conducted on mice and monkeys, allowing it to proceed to tests on humans either in late April or early May. | The ‘ChulaCov19’ vaccine has proved effective in tests that have been conducted on mice and monkeys, allowing it to proceed to tests on humans either in late April or early May. |
| Announcing the proposed production timeline, Kiat Ruxrungtham, from the Chula Vaccine Research Center, said that “By year-end we should have a production capacity of one to five million doses annually,” suggesting the number could reach as high as 20 million per year. | Announcing the proposed production timeline, Kiat Ruxrungtham, from the Chula Vaccine Research Center, said that “By year-end we should have a production capacity of one to five million doses annually,” suggesting the number could reach as high as 20 million per year. |
| It is not yet clear if the vaccines being produced in Thailand will be effective against new strains of Covid-19, such as the Kent or South African variants. But Chulalongkorn University has said it is already working on new doses that will protect people against mutated viruses. | It is not yet clear if the vaccines being produced in Thailand will be effective against new strains of Covid-19, such as the Kent or South African variants. But Chulalongkorn University has said it is already working on new doses that will protect people against mutated viruses. |
| Another Covid-19 vaccine is being developed in Thailand, as part of research from Mahidol University. However, while it is also scheduled to start human trials shortly, it is not expected to be publicly available, if it gets approved, until the country has begun its domestic production of AstraZeneca vaccines. | Another Covid-19 vaccine is being developed in Thailand, as part of research from Mahidol University. However, while it is also scheduled to start human trials shortly, it is not expected to be publicly available, if it gets approved, until the country has begun its domestic production of AstraZeneca vaccines. |
| The Thai government has faced criticism for its slow Covid-19 vaccine rollout, particularly for its refusal to join the World Health Organization’s COVAX scheme. The country has ordered 26 million doses of the AstraZeneca vaccine, which will be ready to use in June, with a view to distributing 10 million doses per month after that. | The Thai government has faced criticism for its slow Covid-19 vaccine rollout, particularly for its refusal to join the World Health Organization’s COVAX scheme. The country has ordered 26 million doses of the AstraZeneca vaccine, which will be ready to use in June, with a view to distributing 10 million doses per month after that. |
| Public health minister Anutin Charnvirakul had initially suggested that 50,000 doses would be received this month from AstraZeneca but has since walked back that claim, stating it was a request, “not an agreement.” | Public health minister Anutin Charnvirakul had initially suggested that 50,000 doses would be received this month from AstraZeneca but has since walked back that claim, stating it was a request, “not an agreement.” |
| Like this story? Share it with a friend! | Like this story? Share it with a friend! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |